Showing results (11-20 of 108) with videos related to
Sort By:
Pageof 11
Cancer Management and Research|December 6, 2019
Real-World Data Of Osimertinib In Patients With Pretreated Non-Small Cell Lung Cancer: A Retrospective StudyYuxin Mu, Puyuan Xing, Xuezhi Hao, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|January 13, 2012
[Clinical response to gefitinib retreatment of lung adenocarcinoma patients who benefited from an initial gefitinib therapy: a retrospective analysis]Junling Li, Xuezhi Hao, Yan Wang, et al.Cancer Management and Research|June 13, 2022
Bevacizumab Combined with Continuation of EGFR-TKIs in NSCLC Beyond Gradual ProgressionZiyi Xu, Fei Teng, Xuezhi Hao, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 27, 2016
[Utility of NSE, ProGRP and LDH in Diagnosis and Treatment in Patients with Small Cell Lung Cancer]Yan Peng, Yan Wang, Junling Li, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 21, 2016
[Recombinant Human Endostatin in the Treatment of Advanced Lung Squamous Cell Carcinoma]Puyuan Xing, Xuezhi Hao, Xingsheng Hu, et al.Thoracic Cancer|June 28, 2021
Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutationZiyi Xu, Xuezhi Hao, Lin Lin, et al.Cancer Innovation|December 13, 2023
Adjuvant and neo-adjuvant immunotherapy in resectable non-small cell lung cancer (NSCLC): Current status and perspectivesZiyi Xu, Zihua Zou, Xuezhi Hao, et al.Thoracic Cancer|July 8, 2016
Clinical effect of pemetrexed as the first-line treatment in Chinese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancerDi Ma, Xuezhi Hao, Yan Wang, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 25, 2017
[Utility of Multiple Increased Lung Cancer Tumor Markers in Treatment of Patients with Advanced Lung Adenocarcinoma]Yan Peng, Yan Wang, Xuezhi Hao, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 21, 2016
[Clinical Analysis of 58 Patients with Small Cell Lung Cancer Combined with Squamous Cell Cancer]Yang Luo, Yu Men, Zhouguang Hui, et al.Pageof 11